On Wednesday, Manulife Financial Corporation (USA) (NYSE:MFC)’s shares inclined 0.83% to $19.41.
Manulife Financial Corporation (USA) (MFC) declared that it has designated Claude Chene as Global Head of Distribution, effective July 1, 2015. Based in London, England, Mr. Chene will report to Kai Sotorp, President and CEO of Manulife Asset Administration and Global Head of Wealth and Asset Administration for Manulife.
In this position, a new role for the organization, Mr. Chene will join the firm’s Executive Committee, and be responsible for creating the distribution vision and strategy, in addition to overseeing sales and relationship administration activity for Manulife Asset Administration on a global basis.
Manulife Financial Corporation, together with its auxiliaries, provides financial protection and wealth administration products and services to individual, corporate, and business customers primarily in Asia, Canada, and the United States. It offers various individual life and health insurance, and individual and group long-term care insurance products through insurance agents, brokers, banks, financial planners, and direct marketing.
Boeing Co (NYSE:BA)’s shares gained 0.79% to $143.47.
Boeing Co (BA) Business Jets declared the sale of the first BBJ MAX 9 recently at the Paris Airshow. The BBJ MAX 9 was ordered by an unrevealed European customer and formerly booked on the Orders & Deliveries website.
The BBJ MAX 9 sale marks the fifth BBJ MAX order. Boeing has formerly booked four orders for the BBJ MAX 8 model.
Boeing Business Jets offers a wide variety of ultra-large-cabin, long range airplanes perfectly suited for the private jet market. The product line comprises the BBJ and BBJ MAX family in addition to Boeing widebody airplanes counting the BBJ 787, 777, and 747-8.
The Boeing Company, together with its auxiliaries, designs, develops, manufactures, sells, services, and supports commercial jetliners, military aircraft, satellites, missile defense, human space flight, and launch systems and services worldwide. The company operates in five segments: Commercial Airplanes, Boeing Military Aircraft, Network & Space Systems, Global Services & Support, and Boeing Capital. The Commercial Airplanes segment develops, produces, and markets commercial jet aircraft for various passenger and cargo requirements, in addition to provides related support services to the commercial airline industry. This segment also offers aviation services support, aircraft modifications, spares, training, maintenance documents, and technical advice to commercial and government customers.
At the end of Wednesday’s trade, First Horizon National Corp (NYSE:FHN)‘s shares dipped -1.22% to $15.36.
First Horizon National Corp (FHN) and its First Tennessee regional bank would remain capitalized at levels significantly better than “adequate” even in severely adverse economic and financial conditions. The annual stress tests, which are designed to ensure banks would have enough capital to operate in economically challenging times, are required of national banks and federal savings associations with assets of at least $10 billion.
The tests measure capital levels — a traditional measure of a bank’s strength — in the face of hypothetical “severely adverse” events specified by regulators including a greater-than-50-percent drop in the U.S. stock market, a greater-than-25-percent drop in U.S. real estate values, a significant contraction of the U.S. economy and a spike in oil prices.
First Horizon National Corporation operates as the bank holding company for First Tennessee Bank National Association that provides various financial services in the United States and internationally. The company offers general banking services for consumers, businesses, financial institutions, and governments. It also provides investments, financial planning, trust, asset administration, credit card, and cash administration services.
22nd Century Group Inc (NYSEMKT:XXII), ended its Wednesday’s trading session with 3.84% gain, and closed at $0.970.
22nd Century Group Inc (XXII) declared that an independent Phase II clinical trial conducted at Queen Mary University of London that explored the efficacy of the Company’s proprietary very low nicotine tobacco as a smoking cessation aid when combined with pharmacotherapy has been accepted for publication in Nicotine & Tobacco Research. The study was supported by a grant from the Global Research Awards for Nicotine Dependence (GRAND) funded by Pfizer, Inc.
The results of this study once again confirm the effectiveness of 22nd Century’s very low nicotine tobacco cigarettes as a smoking cessation aid. The Company’s very low nicotine cigarettes satisfy the behavioral aspect of smoking while delivering only trace amounts of nicotine. Indeed, it is 22nd Century’s fundamental assertion that very low nicotine cigarettes uncouple the behavioral/sensory aspects of smoking from the rapid delivery of nicotine.
22nd Century Group, Inc., a plant biotechnology company, focuses on tobacco harm reduction and smoking cessation products produced from modifying the nicotine content in tobacco plants through genetic engineering and plant breeding. It develops smoking cessation products and modified risk tobacco products for smokers who are unable or unwilling to quit smoking and who may be interested in cigarettes which reduce exposure to certain tobacco smoke toxins and/or pose a lower health risk than conventional cigarettes.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
